RESTRICTION POLICIES FOR THERAPY WITH COMBINATION ANTIBIOTICS

被引:25
作者
QUINTILIANI, R
KLIMEK, JJ
NIGHTINGALE, CH
机构
[1] HARTFORD HOSP,EPIDEMIOL SECT,HARTFORD,CT 06115
[2] HARTFORD HOSP,DEPT PHARM SERV,HARTFORD,CT 06115
[3] UNIV CONNECTICUT,SCH MED,FARMINGTON,CT 06032
[4] UNIV CONNECTICUT,SCH PHARM,STORRS,CT 06268
关键词
D O I
10.1093/infdis/153.4.645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:645 / 647
页数:3
相关论文
共 10 条
[1]  
FAINSTEIN V, 1985, AM J MED S2A, V79, pS83
[2]  
HARDING GKM, 1984, REV INFECT DIS, V6, pS283
[3]   ANTI-MICROBIAL SYNERGISM - ELUSIVE CONCEPT [J].
MOELLERING, RC .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :639-641
[4]  
MOELLERING RC, 1985, AM J MED S2A, V79, pS104
[5]  
QUINTILIANI R, 1985, CONTROLLING ANTIBIOT
[6]   THE INFLUENCE OF DOSE FREQUENCY AND AGENT TOXICITY ON THE COST OF PARENTERAL ANTIBIOTIC-THERAPY [J].
RAPP, RP ;
BANNON, CL ;
BIVINS, BA .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (12) :935-938
[7]   HOME INTRAVENOUS ANTIBIOTIC-THERAPY - A TEAM-APPROACH [J].
REHM, SJ ;
WEINSTEIN, AJ .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) :388-392
[8]   A RANDOMIZED COMPARISON OF CEFOXITIN WITH OR WITHOUT AMIKACIN AND CLINDAMYCIN PLUS AMIKACIN IN SURGICAL SEPSIS [J].
TALLY, FP ;
MCGOWAN, K ;
KELLUM, JM ;
GORBACH, SL ;
ODONNELL, TF .
ANNALS OF SURGERY, 1981, 193 (03) :318-323
[9]  
TALLY FP, 1985, AM J MED S6A, V78, pS145
[10]  
TANNER DJ, 1984, REV INFECT DIS, V6, pS924